SC-51322

• CAT Number: R051802
• CAS Number: 146032-79-3
• Molecular Formula: C22H20ClN3O4S
• Molecular Weight: 457.93
• Purity: ≥95%
• Synonyms: 3-chloro-N’-[3-(furan-2-ylmethylsulfanyl)propanoyl]-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide
• IUPAC Name: 3-chloro-N'-[3-(furan-2-ylmethylsulfanyl)propanoyl]-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide
• InChI: InChI=1S/C22H20ClN3O4S/c23-16-7-8-20-18(12-16)26(13-15-4-1-2-6-19(15)30-20)22(28)25-24-21(27)9-11-31-14-17-5-3-10-29-17/h1-8,10,12H,9,11,13-14H2,(H,24,27)(H,25,28)
• InChIKey: CQBVTZDISUKDSX-UHFFFAOYSA-N
• SMILES: C1C2=CC=CC=C2OC3=C(N1C(=O)NNC(=O)CCSCC4=CC=CO4)C=C(C=C3)Cl

SC-51322（Cat No.:R051802）is a selective nonsteroidal antagonist of the prostaglandin E2 receptor EP1, which is involved in mediating inflammatory and pain responses. By blocking EP1 receptor activation, SC-51322 inhibits calcium signaling and downstream pro-inflammatory effects associated with prostaglandin E2 (PGE2). It is widely used in pharmacological studies to investigate the role of EP1 in nociception, neuroinflammation, and other PGE2-driven physiological and pathological processes. SC-51322 serves as a valuable research tool for exploring targeted anti-inflammatory strategies and understanding EP1 receptor signaling in conditions such as pain, arthritis, and neurodegenerative diseases.